-
Novo Nordisk sues 2 Florida pharmacies for allegedly selling impure weight-loss drugs
Novo Nordisk's lawsuits allege that the pharmacies' products claiming to contain the active ingredient for its in-demand weight-loss drug Wegovy were impure. -
Pfizer, Astellas obtain FDA OK for Xtandi
Xtandi is the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer.